Mr. Covert is a director in the Biotechnology/Chemical Group.  His practice is focused in technologies that involve organic chemistry, such as pharmaceuticals, coatings, fuels, lubricants and pesticides.  He is experienced in a number of interdisciplinary areas, including computer-aided drug design, combinatorial chemistry and medical devices.  He provides counseling with regard to patent portfolio strategy and management with issues that range from licensing, collaborations and technology acquisitions, to patent validity, infringement and design around strategies.

Mr. Covert has performed intellectual property due diligence investigations on behalf of clients seeking to acquire early and late stage pharmaceutical product candidates, drug design platforms, technology for controlling biological reactions, and assisted in all aspects of technology transfer in the pharmaceutical and biotechnology fields.